A Prospective Cohort Study on the Management of Young Patients with Newly Diagnosed Type 2 Diabetes Using Mobile Medical Applications
Tóm tắt
The aim of this study was to evaluate the effect of using a mobile medical application (app) for self-monitoring of blood glucose (SMBG) and blood glucose control in young patients with newly diagnosed type 2 diabetes mellitus (T2DM). This was a prospective cohort study involving young patients with newly diagnosed T2DM. On a voluntary basis, the patients chose to be included in a group in which they were followed up for 24 weeks with a mobile medical app and the changes in laboratory data and frequency of SMBG observed via the app, or in a group in which they received traditional medical treatment and follow-up. The results between the two groups were compared. A total of 126 patients signed the informed consent form and were enrolled in the study, of whom 66 chose the mobile medical group, which used the mobile medical app, and the remaining 60 patients chose the traditional medical treatment model. The differences in the physical and chemical indicators between the app-using group and the traditional medical model group were not statistically significant at baseline (p > 0.05). At 24 weeks of treatment, the levels of glycosylated hemoglobin A1c (HbA1c), total cholesterol, triglycerides, and low-density lipoprotein cholesterol were significantly reduced in all patients compared to before treatment (p < 0.05). The app-using group had a higher HbA1c compliance rate and higher frequency of both SMBG and doctor–patient communication than the traditional medical model group (p < 0.01). The HbA1c compliance rate of patients using the mobile medical app was 1.53-fold higher than that of the traditional medical model group. At 24 weeks, HbA1c was negatively correlated with the frequency of SMBG (r = − 0.208, p = 0.020) and the frequency of doctor–patient communication (r = − 0.323, p = 0.000). Additionally, there was a positive correlation between the frequency of SMBG and doctor–patient communication (r = 0.579, p = 0.000). A mobile medical app is helpful to young patients with newly diagnosed T2DM for monitoring their blood glucose level and improving their blood glucose control to meet the standard.
Tài liệu tham khảo
Chinese diabetes society. China guideline for type 2 diabetes (the 2017 edition). Chin J Pract Intern Med. 2018;4:292–344.
Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–59.
Wang YR, Wang Q, Li LN, et al. Diabetic patients’ willingness to use mobile health services and the correlation factors. Chin Gen Pract. 2017;20(13):1619–25.
Iyengar V, Wolf A, Brown A, Close K. Challenges in diabetes care: can digital health help address them. Clin Diabetes. 2016;34(3):133–41.
Chinese diabetes society. China guideline for type 2 diabetes (the primary hospital edition). Chin J Gen Practitioners. 2013;12(8):675–96.
Ray KK, Seshasai SR, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373(9677):1765–72.
Xiaohui Guo, Liming Chen, Li Chen, et al. Effectiveness evaluation of the mobile health patients management mode on treatment compliance and glycemic control for type 2 diabetes patients using basal insulin treatment for 12 weeks. Chin J Endocrinol Metab. 2016;32(8):639–46.
Marcolino MS, Maia JX, Alkmim MB, Boersma E, Ribeiro AL. Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS One. 2013;8(11):e79246.
Kempf K, Altpeter B, Berger J, et al. Efficacy of the telemedical lifestyle intervention program TeLiPro in advanced stages of type 2 diabetes: a randomized controlled trial. Diabetes Care. 2017;40(7):863–71.
Lee JM, Newman MW, Gebremariam A, et al. Real-world use and self- reported health outcomes of a patient-designed do-it-yourself mobile technology system for diabetes: lessons for mobile health. Diabetes Technol Ther. 2017;19(4):209–19.
Offringa R, Sheng T, Parks L, Clements M, Kerr D, Greenfield MS. Digital diabetes management application improves glycemic outcomes in people with type 1 and type 2 diabetes. J Diabetes Sci Technol. 2018;12(3):701–8.
Fjeldsoe BS, Marshall AL, Miller YD. Behavior change interventions delivered by mobile telephone short-message service. Am J Prev Med. 2009;36(2):165–73.
Siminerio L, Ruppert K, Huber K, Toledo FG. Telemedicine for reach, education, access, and treatment (TREAT): linking telemedicine with diabetes self-management education to improve care in rural communities. Diabetes Educ. 2014;40(6):797–805.